
Eikon Therapeutics, Inc. Common Stock
EIKNHealthcare|Biotechnology|US
$5.90
+0.06 (+1.03%)
Tangible Book / Share
$8.62
Cash / Share
$9.82
Ownership Breakdown
55.1%
Float
54.1M
Shares Outstanding
29.8M
Float Shares
Major Holders (29)
Combined: 121.1%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Tim Kutzkey | Individual | 11.60% | 6,353,712 | Feb 12, 2026 | 13D/G |
| Peter Svennilson | Individual | 11.60% | 6,353,712 | Feb 12, 2026 | 13D/G |
| Abigail P. Johnson | Individual | 10.20% | 5,520,152 | Oct 7, 2026 | 13D/G |
| FMR LLC | Holding company | 10.20% | 5,520,152 | Oct 7, 2026 | 13D/G |
| The Column Group IV GP, LP | Partnership | 8.30% | 4,460,979 | Feb 12, 2026 | 13D/G |
| The Column Group IV, LP | Partnership | 8.00% | 4,312,139 | Feb 12, 2026 | 13D/G |
| James B. Tananbaum | Individual | 7.70% | 4,148,519 | Feb 11, 2026 | 13D/G |
| BlackRock Portfolio Management LLC | Holding company | 5.50% | 3,002,737 | Apr 29, 2026 | 13D/G |
| Perlmutter Roger M | Individual | 5.20% | 2,893,171 | May 13, 2026 | 13D/G |
| Innovation Endeavors III LP | Partnership | 5.00% | 2,723,226 | May 15, 2026 | 13D/G |
| Innovation Endeavors III GP, LLC | Other | 5.00% | 2,723,226 | May 15, 2026 | 13D/G |
| Foresite Capital Fund IV, L.P. | Partnership | 3.60% | 1,960,774 | Feb 11, 2026 | 13D/G |
| Foresite Capital Management IV, LLC | Other | 3.60% | 1,960,774 | Feb 11, 2026 | 13D/G |
| TCG Opportunity III GP, LLC | Other | 3.50% | 1,892,733 | Feb 12, 2026 | 13D/G |
| The Column Group Opportunity III, LP | Partnership | 3.50% | 1,892,733 | Feb 12, 2026 | 13D/G |
| The Column Group Opportunity III GP, LP | Partnership | 3.50% | 1,892,733 | Feb 12, 2026 | 13D/G |
| Foresite Capital Management V, LLC | Other | 2.50% | 1,353,168 | Feb 11, 2026 | 13D/G |
| Foresite Capital Fund V, L.P. | Partnership | 2.50% | 1,353,168 | Feb 11, 2026 | 13D/G |
| Platinum Falcon B 2018 RSC Limited | Corporation | 2.10% | 1,147,138 | Oct 2, 2026 | 13D/G |
| Abu Dhabi Investment Authority | Other | 2.10% | 1,147,138 | Oct 2, 2026 | 13D/G |
| Innovation Endeavors IV LP | Partnership | 0.90% | 498,474 | May 15, 2026 | 13D/G |
| Innovation Endeavors IV GP, LLC | Other | 0.90% | 498,474 | May 15, 2026 | 13D/G |
| Foresite Capital Opportunity Management V, LLC | Other | 0.80% | 425,852 | Feb 11, 2026 | 13D/G |
| Foresite Capital VI-A, LLC | Other | 0.80% | 408,725 | Feb 11, 2026 | 13D/G |
| Foresite Capital VI-A Management, LLC | Other | 0.80% | 408,725 | Feb 11, 2026 | 13D/G |
| Foresite Capital Opportunity Fund V, L.P. | Partnership | 0.80% | 425,852 | Feb 11, 2026 | 13D/G |
| Innovation Endeavors ET SPV LP | Partnership | 0.30% | 147,819 | May 15, 2026 | 13D/G |
| Innovation Endeavors ET SPV GP LLC | Other | 0.30% | 147,819 | May 15, 2026 | 13D/G |
| The Column Group IV-A, LP | Partnership | 0.30% | 148,840 | Feb 12, 2026 | 13D/G |
Insider Trades (1)
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Column Group IV GP, LP | 10 percent owner | Sep 3, 2026 | BUY | 89,200 | $11.56 | $1.0M | Form 4 |